Beta Drugs Ltd vs Hester Biosciences Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 13, 2026

Key Highlights

The Latest Trading Price of Beta Drugs Ltd is ₹ 1771 as of 12 Jun 15:30 . The P/E Ratio of Beta Drugs Ltd changed from 9.8 on March 2021 to 45.3 on March 2025 . This represents a CAGR of 35.82% over 5 yearsThe P/E Ratio of Hester Biosciences Ltd changed from 47.4 on March 2021 to 38.8 on March 2025 . This represents a CAGR of -3.92% over 5 years The Market Cap of Beta Drugs Ltd changed from ₹ 115.37 crore on March 2021 to ₹ 1923 crore on March 2025 . This represents a CAGR of 75.55% over 5 yearsThe Market Cap of Hester Biosciences Ltd changed from ₹ 1630 crore on March 2021 to ₹ 1066 crore on March 2025 . This represents a CAGR of -8.14% over 5 years The revenue of Beta Drugs Ltd for the Mar '26 is ₹ 96.86 crore as compare to the Dec '25 revenue of ₹ 89.58 crore. This represent the growth of 8.13% The revenue of Hester Biosciences Ltd for the Mar '26 is ₹ 101.88 crore as compare to the Dec '25 revenue of ₹ 79.4 crore. This represent the growth of 28.31% The ebitda of Beta Drugs Ltd for the Mar '26 is ₹ 20.57 crore as compare to the Dec '25 ebitda of ₹ 19.3 crore. This represent the growth of 6.58% The ebitda of Hester Biosciences Ltd for the Mar '26 is ₹ 36.1 crore as compare to the Dec '25 ebitda of ₹ 19.78 crore. This represent the growth of 82.51% The net profit of Beta Drugs Ltd changed from ₹ 8.95 crore to ₹ 9.05 crore over 6 quarters. This represents a CAGR of 0.74% The net profit of Hester Biosciences Ltd changed from ₹ 7.49 crore to ₹ 16.55 crore over 8 quarters. This represents a CAGR of 48.65% The Dividend Payout of Beta Drugs Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Hester Biosciences Ltd changed from 21.33 % on March 2021 to 18.71 % on March 2025 . This represents a CAGR of -2.59% over 5 years .

About Beta Drugs Ltd

Beta Drugs Limited was incorporated as a private limited company with the name 'Beta Drugs Private limited' at Himachal Pradesh on September 21, 2005.
Subsequently, the company was converted in to public limited company and the name of the company was changed to 'Beta Drugs Limited' on August 11, 2017 Beta Drugs is a part of Adley Group.
Adley Group was founded in the year 1985, by its promoter Vijay Batra, who has more than twenty five years of experience in manufacture of pharmaceutical products in India.
The Company is a pharmaceutical formulation manufacturing company engaged in developing, manufacturing and marketing of drug products for domestic and international customers.
The Promoter Vijay Batra, took over the company from Kiran Goyal, Deepak Kumar Prince Bharti and Rohit Bansal in the year 2014.

About Hester Biosciences Ltd

Hester Biosciences Limited is one of the leading and pioneering animal healthcare companies in India.
The Company was incorporated in April, 1987 and is engaged in manufacturing of Poultry vaccines and Large Animal Vaccines and trading of Poultry and Large animal and Petcare health products having its manufacturing set up at Meda Adraj Village, Mehsana District, Gujarat. The Company built a presence in several regions of Africa and in numerous nations, including Vietnam, Indonesia, Nepal, and Bangladesh.
The products and services included over 51 vaccines and 70+ health products.
In addition, it offers a vast selection of pharmaceuticals, feed supplements, and disinfectants for poultry and large animals. The Company markets and distributes veterinary and pharmaceutical products like animal health products, poultry vaccines, poultry diagnostic, laboratory kits and reagents.

FAQs for the comparison of Beta Drugs Ltd and Hester Biosciences Ltd

Which company has a larger market capitalization, Beta Drugs Ltd or Hester Biosciences Ltd?

Market cap of Beta Drugs Ltd is 1,795 Cr while Market cap of Hester Biosciences Ltd is 1,667 Cr

What are the key factors driving the stock performance of Beta Drugs Ltd and Hester Biosciences Ltd?

The stock performance of Beta Drugs Ltd and Hester Biosciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Beta Drugs Ltd and Hester Biosciences Ltd?

As of June 13, 2026, the Beta Drugs Ltd stock price is INR ₹1771.2. On the other hand, Hester Biosciences Ltd stock price is INR ₹1960.4.

How do dividend payouts of Beta Drugs Ltd and Hester Biosciences Ltd compare?

To compare the dividend payouts of Beta Drugs Ltd and Hester Biosciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.